Patent number: 10386378
Abstract: A method of diagnosing a prostate condition in a subject comprises determining, in a sample obtained from a subject, levels of a plurality of constituents selected from the group consisting of Ca, K, Mg, Zn, Ag, Al, Au, B, Ba, Bi, Br, Cd, Ce, Co, Cr, Cs, Cu, Dy, Er, Fe, Gd, Hg, Ho, La, Li, Mn, Na, Nd, Ni, P, Pb, Pr, Rb, S, Sb, Sc, Se, Si, Sm, Sr, Tb, Th, Tl, U, Y, and Zr. A combination of the levels of the plurality of constituents in the sample is compared with a combination of control levels of the same plurality of constituents. A difference between the combinations is indicative of the prostate condition.
Type:
Grant
Filed:
May 19, 2015
Date of Patent:
August 20, 2019
Assignee:
CAMBRIDGE ONCOMETRIX LIMITED
Inventors:
Sofia Zaichik, Maxim Rossmann, Dmitry Solovyev, Mikhail Lomonosov, Vladimir Zaychik